# The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol

> **NCT03145636** · NA · UNKNOWN · sponsor: **ReShape Lifesciences** · enrollment: 4 (actual)

## Conditions studied

- Obesity, Morbid

## Interventions

- **DEVICE:** vBloc Maestro Rechargeable System
- **OTHER:** vBloc Achieve Weight Management Program
- **OTHER:** Control Weight Management (CWM) program

## Key facts

- **NCT ID:** NCT03145636
- **Lead sponsor:** ReShape Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-30
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145636, "The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03145636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*